Novavax Inc (NVAX)

227.35
+25.26(+12.50%)
After Hours
226.00
-1.35(-0.59%)
- Real-time Data
  • Volume:
    4,510,957
  • Bid/Ask:
    225.20/226.75
  • Day's Range:
    200.50 - 228.10

NVAX Overview

Prev. Close
202.09
Day's Range
200.5 - 228.1
Revenue
475.6M
Open
201.71
52 wk Range
16.41 - 331
EPS
-6.79
Volume
4,510,957
Market Cap
16.79B
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
4,346,115
P/E Ratio
N/A
Beta
1.51
1-Year Change
1,156.08%
Shares Outstanding
73,858,882
Next Earnings Date
Aug 10, 2021
What is your sentiment on Novavax Inc?
or
Market is currently closed. Voting is open during market hours.

Novavax Inc News

Novavax Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy

Novavax Inc Company Profile

Novavax Inc Company Profile

Employees
791

Novavax, Inc. is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through developing recombinant vaccines segment. The Company, through its recombinant nanoparticle vaccine technology, produces vaccine candidates to respond to both known and newly emerging diseases. The Company's product pipeline focuses on a range of infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus (RSV), seasonal influenza, pandemic influenza and the Ebola virus (EBOV). The Company's lead adjuvant for human applications, Matrix-M, is in a Phase I/II clinical trial for pandemic influenza H7N9 vaccine candidate. It is also testing Matrix-M in conjunction with its EBOV vaccine candidate in a Phase I clinical trial. It is developing additional pre-clinical stage programs in a range of infectious diseases, including Middle East respiratory syndrome (MERS).

Read More
  • scam stock. should be $150.
    2
    • Why would a scam be worth $150?
      0
  • Just for kicks and giggles y'all should compare CVAC to NVAX. TTM revenue and market cap. It's embarrassing.
    0
    • WSJ article posted minutes ago states that annual COVID boosters are required.
      0
      • Thoughts anyone. I think the best thing is to hold and wait for the FDA phase 3 approval. Then it's up again. Could come any day now.
        0
        • si la FDA la aprueba se dispara al fin
          0
        • TP $ 330 or more with FDA approval
          0
        • When is phase 3 approval?
          0
      • we can see a peak of 220 by the evening✌
        0
        • Missed it by a couple days, but we're there!
          0
        • 227
          0
      • You guys are making banks.
        1
        • Novavax could receive UK regulatory authorization for its vaccine as early as this month after releasing impressive UK trial data. It anticipates clearance in the United States could come as early as May after soon-to-be released data from its U.S. vaccine trial are reviewed by regulators.
          2
          • They have just announced that there are further delays due to certain packaging supply issues. How is this a good news when no they moved to 3rd quarter
            7
            • So why did it go down from 320 to 150 if delaying means nothing?
              2
            • same reason the market went down during that same time frame. correction panic selling profit taking..10yr yield rates FED talk inflation etc....where u been last few weeks.
              2
            • @Jose Cabreja really? Same reason for %60 down? Which market was %60 down? Check the orher vaccine companies while market was down. Where u been then?
              1
          • Why is this stock going up so much today?
            3
            • Because FDA and CDC pause J&J vaccine.
              1
          • hit 200+
            1
            • This stock makes me crazy. I really need a good news!!!
              1
              • cheetahs go back when it starts jump.
                1
            • Why is going down again???
              1
              • Big short interest Think reddit.
                4
                • why is it tanking
                  0
                  • https://www.fool.com/investing/2021/04/10/how-important-is-novavaxs-covid-vaccine-manufactur/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article aunque es noticia de hace una semana creo este articulo es alentador ...
                    0
                    • https://www.bloomberg.com/news/articles/2021-04-09/eu-regulator-investigating-blood-clots-after-j-j-covid-vaccine
                      0
                      • Any opinion on the daily candle chart? There is a text book drop base drop with a color change candle as the base. I'm short from $182.00
                        1
                        • Europe's medical regulator has opened an investigation into possible links between Johnson & Johnson's (JNJ) COVID-19 vaccine and blood clotting events.”
                          0
                          • Who cares J and J?!!! What is your point?
                            0
                          • That nvax competitor has bad news out
                            0
                          • It is a good news for Novavax
                            0
                        • Milestone announments for eu approval and filing for eua in us early in Q2. Also crossover vaccinations are a sign of a successful drug and medically ethics requiring those getting the placebo should be given the drug. You just dont see crossover unless the drug is highly successful.
                          0
                          • https://abc7chicago.com/vaccine-effectiveness-covid-19-variants-against/10494822/
                            0
                            • Short squeeze is comming
                              5
                              • why do you think, please?
                                0
                              • Based on what?
                                0
                            • Economy revamp is needed, and good news about this vaccine too.... like the supply issue
                              0
                              • Why it s dropping again????
                                0
                                • look at the volume, shortees....
                                  0
                              • Is NVAX being sold as a single shot too?https://www.essexlive.news/news/uk-world-news/essex-covi-single-shot-vaccine-5264089
                                0
                                • Nasdaq and SP 500 are promising. It can be closed above 195 today. Don't sell!
                                  13
                                  • I sold it myself, sorry for this comment.
                                    10
                                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.